The triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer characterized by the absence of estrogen receptors (ER), progesterone receptors (PR) and human epidermal growth factor receptor type 2 (HER2) overexpression [1]. This evidence concerns the gene ERBB2 and breast cancer.